Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study of the Determinants of Transdermal Drug Delivery to the Normal and the Radiated Breast

NCT04009044 is registered in ClinicalTrials.gov with Northwestern University as lead sponsor.

NCT NCT04009044
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04009044 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study of the Determinants of Transdermal Drug Delivery to the Normal and the Radiated Breast
Lead sponsor
Northwestern University
Phase
Phase 2
Overall status
Active, not recruiting
Start date
February 17, 2020
Completion date
June 25, 2026
Enrollment
156 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cancer survivor, ductal breast carcinoma in situ, invasive breast carcinoma